Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthetic method of oxazoline medical intermediate compound

A synthesis method and compound technology, which are applied in the fields of organic synthesis, synthesis of oxazoline compounds, and synthesis of heteroatom-containing compounds, can solve the problems such as the reaction yield needs to be improved, the scope of application is narrow, etc., and achieve wide application prospects and industrialization. The effect of applying potential

Active Publication Date: 2015-08-05
JILIN BAINIAN HANKE PHARM CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] As mentioned above, although a variety of methods for synthesizing such compounds have been disclosed in the prior art, these methods have many problems such as a narrow scope of application, and the reaction yield still needs to be improved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method of oxazoline medical intermediate compound
  • Synthetic method of oxazoline medical intermediate compound
  • Synthetic method of oxazoline medical intermediate compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039]

[0040] At room temperature, add 100 mmol of the above formula (I) compound, 4 mmol of the catalyst 1-benzyl-3-methylimidazolium bromide, 100 mmol of p-nitrobenzenesulfonic acid, and 10 mmol of the above-mentioned organic phosphine ligand L1 to an appropriate amount of organic solvent DMSO and 100 mmol 2-iodoethyl methyl ether, and the temperature was raised to 40° C. and the reaction was stirred at this temperature for 8 hours.

[0041] After the reaction, the pH value of the reaction solution was adjusted to 7-7.5 with a 10% NaOH aqueous solution with a concentration of 10% by mass, then fully washed 2-3 times with deionized water, then extracted 2-3 times with dichloromethane, and combined organic phase, dried with anhydrous sodium sulfate, filtered, the filtrate was concentrated in vacuo, and the residue was subjected to 300-400 mesh silica gel column chromatography, using a mixture of ethyl acetate and chloroform with a volume ratio of 1:2 as the eluent, thereby...

Embodiment 2

[0044]

[0045]At room temperature, add 100mmol of the above formula (I) compound, 8mmol catalyst 1-benzyl-3-methylimidazolium chloride, 125mmol p-nitrobenzenesulfonic acid, 20mmol of the above-mentioned organic phosphine ligand L1 to an appropriate amount of organic solvent DMSO and 150 mmol 2-iodoethyl methyl ether, and the temperature was raised to 60° C. and the reaction was stirred at this temperature for 6 hours.

[0046] After the reaction is finished, the pH value of the reaction solution is adjusted to 7-7.5 with a 10% NaOH aqueous solution by mass percentage concentration, then fully washed 2-3 times with deionized water, the organic phases are combined, dried with anhydrous sodium sulfate, filtered, The filtrate was concentrated in vacuo, and the residue was subjected to 300-400 mesh silica gel column chromatography, using a mixture of ethyl acetate and chloroform at a volume ratio of 1:3 as the eluent, thereby obtaining the compound of the above formula (II), wit...

Embodiment 3

[0049]

[0050] At room temperature, add 100 mmol of the above formula (I) compound, 6 mmol of the catalyst 1-benzyl-3-methylimidazolium bromide, 150 mmol of p-nitrobenzenesulfonic acid, and 15 mmol of the above-mentioned organic phosphine ligand L1 to an appropriate amount of organic solvent DMSO and 200 mmol 2-iodoethyl methyl ether, and the temperature was raised to 80° C. and the reaction was stirred at this temperature for 4 hours.

[0051] After the reaction is finished, the pH value of the reaction solution is adjusted to 7-7.5 with a 10% NaOH aqueous solution by mass percentage concentration, then fully washed 2-3 times with deionized water, the organic phases are combined, dried with anhydrous sodium sulfate, filtered, The filtrate was concentrated in vacuo, and the residue was subjected to 300-400 mesh silica gel column chromatography, using a mixture of ethyl acetate and chloroform at a volume ratio of 1:4 as the eluent to obtain the compound of formula (II) with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a synthetic method of an oxazoline compound represented as the formula (II). The synthetic method includes a step of carrying out a reaction to a compound represented as the following formula (I) with an iodine ether compound to generate the compound represented as the formula (II) in an organic solvent in the presence of a catalyst, an organic acid and an organic phosphine ligand, wherein R is H, a C1-C6 alkyl group, a C1-C6 alkoxyl group or halogen and n is an integer from 1 to 4. The synthetic method includes optimizing selection on the catalyst, the organic acid, the organic phosphine ligand, the iodine compound and the organic solvent to finally obtain a most preferably reaction system, by which the targeted product can be prepared at a high yield. The synthetic method is simple in post-treatment, is short in required time, is a convenient synthetic method for preparation and production of medical and chemical products and has a wide market prospect.

Description

technical field [0001] The invention relates to a method for synthesizing heteroatom-containing compounds, more particularly to a method for synthesizing oxazoline compounds that can be used as pharmaceutical intermediates, and belongs to the technical field of organic synthesis, especially the synthesis of pharmaceutical intermediates. Background technique [0002] Because oxazoline contains both oxygen and nitrogen atoms in its structure, it has a variety of pharmaceutical activities, and has become the basic building block and pharmaceutical intermediate of pharmacodynamic activity. For example, Lue pyrrins with this type of structure have antifungal and eukaryotic functions, and can be used to resist cancer; dihydrooxazines are also known to have antibacterial activity. It can be seen that the study of new synthetic methods for oxazoline compounds is very important for the research and development and manufacture of drugs, and it plays a decisive role in the development ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D263/14C07D265/08C07D267/06
CPCC07D263/14C07D265/08C07D267/06
Inventor 刘增峰
Owner JILIN BAINIAN HANKE PHARM CO LTD